Ultra-Low-Dose Rituximab Induces Persistently Low B-Cell Counts: A Case Report of Pemphigus Vulgaris
Clinical, Cosmetic and Investigational Dermatology · 2026-11 · Volume 19 · 1-10
DOI: 10.2147/ccid.s651293 ↗Kurz gefasst
Fallbericht in der Zeitschrift Clinical, Cosmetic and Investigational Dermatology, 2026-11. Verfasst von Tianhao Li und 7 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Li, T., Li, Z., Gu, J., Chen, S., Ye, M., Tian, Y., Zuo, X., & Xie, C. (2026). Ultra-Low-Dose Rituximab Induces Persistently Low B-Cell Counts: A Case Report of Pemphigus Vulgaris. Clinical, Cosmetic and Investigational Dermatology, Volume 19, 1-10. https://doi.org/10.2147/ccid.s651293
Vancouver
Li T, Li Z, Gu J, Chen S, Ye M, Tian Y, et al. Ultra-Low-Dose Rituximab Induces Persistently Low B-Cell Counts: A Case Report of Pemphigus Vulgaris. Clinical, Cosmetic and Investigational Dermatology. 2026;Volume 19:1-10. doi:10.2147/ccid.s651293
BibTeX
@article{Li2026,
author = {Li, Tianhao and Li, Ziqing and Gu, Jiefang and Chen, Siyan and Ye, Maogen and Tian, Ye and Zuo, Xiaohong and Xie, Chunguang},
title = {Ultra-Low-Dose Rituximab Induces Persistently Low B-Cell Counts: A Case Report of Pemphigus Vulgaris},
journal = {Clinical, Cosmetic and Investigational Dermatology},
year = {2026},
volume = {Volume 19},
pages = {1--10},
doi = {10.2147/ccid.s651293}
}
EUVIMED